Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint Infections
Despite its efficacy and toxicity being exposure-related, levofloxacin pharmacokinetics in patients with bone and joint infections has been poorly described to date, so the possible need for a dose adjustment is unknown in this population. A prospective population pharmacokinetic study was conducted...
Main Authors: | Gauthier Eloy, David Lebeaux, Manon Launay, Marie-Paule Fernandez-Gerlinger, Eliane Billaud, Emmanuel Douez, Jean-Luc Mainardi, Benjamin Bouyer, Vincent Jullien |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/7/401 |
Similar Items
-
Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01) -
Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study
by: Watsamon Jantarabenjakul, et al.
Published: (2022-09-01) -
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
by: Sidamo T, et al.
Published: (2022-11-01) -
A Case of Listeria monocytogenes Bacteremia Treated with Levofloxacin
by: Ferit ÇELİK, et al.
Published: (2014-12-01) -
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
by: Manuel López-López, et al.
Published: (2019-01-01)